- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/06 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies from serum
Patent holdings for IPC class C07K 16/06
Total number of patents in this class: 1091
10-year publication summary
|
55
|
64
|
82
|
125
|
95
|
77
|
91
|
77
|
60
|
48
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2726 |
40 |
| Regeneron Pharmaceuticals, Inc. | 4461 |
39 |
| Genentech, Inc. | 4016 |
35 |
| Amgen Inc. | 4264 |
34 |
| Cytiva BioProcess R&D AB | 309 |
32 |
| Hoffmann-La Roche Inc. | 3548 |
31 |
| CSL Behring AG | 180 |
31 |
| F. Hoffmann-La Roche AG | 7932 |
29 |
| Biotest AG | 113 |
21 |
| Plasma Technologies, LLC | 31 |
15 |
| Bristol-myers Squibb Company | 4821 |
12 |
| ADMA Biomanufacturing, LLC | 32 |
12 |
| AbbVie Biotechnology Ltd. | 175 |
11 |
| Bio-Rad Laboratories, Inc. | 1618 |
10 |
| Janssen Biotech, Inc. | 1597 |
10 |
| Momenta Pharmaceuticals, Inc. | 294 |
10 |
| EMD Millipore Corporation | 640 |
9 |
| The Johns Hopkins University | 5759 |
9 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 296 |
9 |
| The Rockefeller University | 584 |
9 |
| Other owners | 683 |